Edition:
United Kingdom

People: DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

0.43USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$0.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,593
52-wk High
$1.38
52-wk Low
$0.38

Karah, Hila 

Ms. Hila Karah is Independent Director of the Company. Ms. Karah is an independent business consultant and an investor in several high-tech, biotech and internet companies. From 2006 to 2013, she served as a partner and Chief Investment Officer of Eurotrust Ltd., a family office. From 2002 to 2005, she served as a research analyst at Perceptive Life Sciences Ltd., a New York-based hedge fund. Prior to that, Ms. Karah served as research analyst at Oracle Partners Ltd., a health care-focused hedge fund. Ms. Karah has served as a director in several private and public companies including Intec Pharma, since 2009 and Cyren Ltd since 2008. Ms. Karah holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley, and studied at the University of California, Berkeley-University of California, San Francisco Joint Medical Program. We believe Ms. Karah is qualified to serve on our Board because of her experience as an investor in and advisor to high-tech, biotech and Internet companies.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 41,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 41,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --